Core Laboratories (CLB) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $12.45 +0.48%
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.18, $0.03 better than the analyst estimate of $0.15. Revenue for the quarter came in at $126 million versus the consensus estimate of $125.97 million.
GUIDANCE:
Core Laboratories sees Q4 2022 EPS of $0.17-$0.21, versus the consensus of $0.17. Core Laboratories sees Q4 2022 revenue of $126-131 million, versus the consensus of $129.98 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
